Alliar Completes R$674.2 Million (US$210.6 Million) IPO
11.04.16
This is only gets display when printing
The Firm represented Centro de Imagem Diagnósticos S.A. – Alliar (“Alliar”) in connection with the initial public offering of 33,709,880 shares of its common shares and listing on the São Paulo Stock Exchange (BM&FBovespa). The common shares were offered to the public in Brazil, to certain qualified institutional buyers under Rule 144A in the United States, and to non-U.S. persons outside the United States in reliance upon Regulation S. The offering raised more than R$674.2 million (approximately US$210.6 million) in gross proceeds, pending exercise of the overallotment option. The offering, which closed on November 1, 2016, marks the first initial public offering by a Brazilian company since June 2015.
Alliar is an innovative, leading provider of medical diagnostic services in Brazil, including diagnostic imaging, nuclear medicine and laboratory testing services. Alliar has expanded rapidly through a number of partnerships and recently became a world pioneer in remotely operated MRI equipment.
The Simpson Thacher team included Grenfel S. Calheiros, S. Todd Crider, Thiago A. Spercel, Tosca Augustin and Marcelo B. Lorenzen (Capital Markets – New York and São Paulo); Jonathan Cantor and Michael Badain (Tax – New York); International Associate Luciana Moutinho also provided valuable assistance.